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Abstract 
Background: Although ultrasonography before a vascular access (VA) operation has become popular in recent years, 
benchmarks for the diameter or blood flow of arteries or veins are not defined in Japan. The objective of the present 
study is to analyze the relationship between preoperative US findings and the patency rate of VA in Japanese hemodi-
alysis patients.
Methods: 139 patients with end stage kidney disease were enrolled in this study. They had been given primary 
radiocephalic arteriovenous fistula (AVF) from February 2009 to December 2010 at the Juntendo University Hospital 
and were followed up over 2 years. We defined the interval from the time of AVF creation until first access thrombosis 
or any intervention to maintain or restore blood flow as patency time (primary patency). We examined the correla-
tion between the 2-year primary patency rate of VA and the diameter of the radial artery (RA), brachial artery (BA), 
or cephalic vein at an anastomosis presumptive region by US, the blood flow of RA or BA, as measured by US, age, 
gender, and primary kidney diseases.
Results: The average patency term was 448.6 ± 271.3 days, with the 1-year and 2-year patency rate as 64.0 and 
51.2 %, respectively. The patency rate was significantly lower in elderly patients over the age of 75 and in patients with 
diabetes mellitus. US findings of 2.0 mm or less in the RA diameter also resulted in a noticeably low patency rate. A 
multivariate analysis indicated that those factors were risk factors for early VA failure.
Conclusions: Preoperative US findings of the diameter of RA may involve the patency rate of VA, making it appears 
that an RA of 2.0 mm or more in diameter at an anastomosis region may be more effective for the improvement in the 
patency rate of VA.
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Background
Recently, patients on long-term hemodialysis (HD) ther-
apy have been increasing in Japan. Maintenance of ade-
quate vascular access (VA) for HD is a major problem 
from the standpoint of quality of life in end stage kidney 
disease (ESKD) patients. A native arteriovenous fistula 
(AVF) is the most preferable form of VA (National Kid-
ney Foundation Kidney Disease Outcomes Quality Ini-
tiative 2006; Tordoir et al. 2007). VA failure remains the 
most common cause of morbidity and hospitalization in 
HD patients. Adequate delivery of prescribed HD relies 
on an optimally functioning VA. Therefore, it is very 
important to create a long-term-functioning VA.
Ultrasonography (US) is a mobile, simple and noninva-
sive technique that provides both anatomic (blood ves-
sel lumen and wall) and physiologic (flow measurement) 
data. Although physical examinations have traditionally 
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been used to identify a suitable artery and vein for 
AVF formation (Lok et al. 2005) and a very recent ran-
domized controlled trial (RCT), comparing a selective 
and a routine policy of US before AVF surgery, found no 
significant differences in primary patency and complica-
tion rates (Smith et  al. 2014), US before VA operation 
has become popular in recent years and is recommended 
in some guidelines (National Kidney Foundation Kidney 
Disease Outcomes Quality Initiative 2006; American 
College of Cardiology Foundation Appropriate Use Cri-
teria Task Force et al. 2013). It is considered that the gap 
between the value of preoperative evaluation and the 
missing maturation mainly depends on the experience 
of the VA surgeon (Konner et al. 2013) and preoperative 
US may help the VA surgeon to plan the most appro-
priate AVF configuration, potentially reducing the inci-
dence of VA dysfunctions (Caroli et  al. 2013; Lomonte 
and Basile 2015). It was reported that preoperative US 
improves AVF outcomes (Silva et  al. 1998; Malovrh 
1998; Allon et  al. 2001; Ferring et  al. 2010) and results 
in a marked increase in the placement of AVFs, as well 
as an improvement in the adequacy of forearm fistulas 
for HD (Allon et al. 2001; Mendes et al. 2002). In those 
studies, patients with a minimum cephalic vein (CV) 
diameter of 2–2.5 mm and a minimum arterial diameter 
of 2 mm showed a significantly higher incidence rate of 
functional fistula maturation (Allon et al. 2001; Mendes 
et al. 2002). However, the relationship between US find-
ings, including the diameter of vessels or blood flow of 
artery and patency rate of AVF, has not been reported in 
Japanese HD patients.
The objective of the present study is to analyze the rela-
tionship between patency rate of VA and preoperative 
US findings including the diameter and the blood flow of 
both arteries and veins, and to discuss the clinical benefit 




The baseline characteristics of all Japanese patients 
enrolled in this study are shown in Table  1. The aver-
age of age at VA operation was 65.3 ± 12.3 years old and 
65.5 % of all patients were male (91/139). The etiology of 
42 % of all patients was diabetes mellitus (DM) (58/139). 
The average body weight as measured on the morning 
of the day of operation was 58.40 ±  12.47  kg and body 
height was 160.13 ± 8.71 cm. The average blood pressure 
as measured in the supine position just before operation 
was 163.83 ±  24.92/83.70 ±  14.13  mmHg. The average 
duration between VA operation and first puncture was 
46.56 ± 76.17 days.
US findings previous to the VA operation
The average diameter of CV and radial artery (RA) at 
an anastomosis presumptive region was 2.55  ±  0.69 
and 2.57  ±  0.50  mm, respectively, and the average 
RA blood flow at an anastomosis presumptive region 
was 25.94  ±  18.74  ml/min. The average diameter and 
blood flow of brachial artery (BA) at the elbow was 
4.82 ± 0.75 mm and 87.32 ± 52.52 ml/min, respectively 
(Table 2).
Patency rate
The average patency time was 448.6  ±  271.3  days. The 
1-year and 2-year patency rate was 64.0 and 51.2  %, 
respectively (Fig. 1).
No significant difference was shown in the patency rate 
between male and female patients (upper panel of Fig. 2, 
p = 0.50). By contrast, the patency rate in patients with 
DM (n = 58) was significantly lower than that in patients 
without DM (n =  81) (lower panel of Fig.  2, p =  0.01). 
Furthermore, the patency rate was also significantly 
lower in 75 years or older patients (n = 41) (upper panel 
of Fig. 3, p = 0.04). US findings of 2.0 mm or less in RA 
diameter also resulted in significant low patency rate 
(n = 11) (lower panel of Fig. 3, p = 0.03).
Table 1 Patient characteristics
Data are presented as mean ± standard deviation
VA vascular access, ESKD end stage kidney disease, DM diabetes mellitus
Age at VA operation (years old) 65.3 ± 12.3 (31–90)
Gender (male %, male:female) 65.5 (91:48)
Etiology of ESKD (DM %, DM:non-DM) 41.7 (58:81)
Body height (cm) 160.13 ± 8.71 (142.6–186.1)
Body weight (kg) 58.40 ± 12.47 (33.3–105.9)
Body mass index (kg/m2) 22.64 ± 3.77 (15.30–36.98)
Systolic blood pressure  
(just before operation) (mmHg)
163.83 ± 24.94 (112–222)
Diastolic blood pressure  
(just before operation) (mmHg)
83.70 ± 14.13 (60–140)
Duration between operation  
to puncture (days)
46.56 ± 76.12 (6–652)
Patency time (days) 448.6 ± 271.3 (20–730)
Table 2 Ultrasonography findings prior to the operation
Data are presented as mean ± standard deviation
CV cephalic vein, RA radial artery, BA brachial artery
Diameter of CV (mm) 2.55 ± 0.69 (0.96–4.85)
Diameter of RA (mm) 2.57 ± 0.50 (1.40–4.21)
Blood flow of RA (ml/min) 25.94 ± 18.74 (2.45–147.8)
Diameter of BA (mm) 4.82 ± 0.75 (3.19–7.40)
Blood flow of BA (ml/min) 87.32 ± 52.52 (4.86–320.25)
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Contribution factors to the patency rate of VA
In the univariate analysis, it was indicated that age (75 or 
more years old, hazard ratio (HR) 1.72; 95 % confidence 
intervals (95  % CI) 1.02–2.85), etiology of ESKD (with 
DM, HR 1.86; 95 % CI 1.13–3.07), RA diameter (less than 
2.0  mm, HR 2.76; 95  % CI 1.26–5.37), RA blood flow 
(less than 20  ml/min, HR 2.04; 95  % CI 1.24–3.40) and 
BA blood flow (per 1.0  ml/min increase, HR 0.99; 95  % 
CI 0.99–1.00) were the risk factors to early AVF failure 
(Table 3). By contrast, there was no correlation between 
poor prognosis of VA and gender (female, HR 1.19; 95 % 
CI 0.71–1.97), physical constitution (body height per 
1 cm increase, HR 0.98; 95 % CI 0.96–1.01; body weight 
per 1 kg increase, HR 1.00; 95 % CI 0.98–1.02, body mass 
index per 1 kg/m2 increase, HR 1.03; 95 % CI 0.97–1.09), 
blood pressure (systolic per 1 mmHg increase, HR 1.00; 
95  % CI 0.99–1.01, diastolic per 1  mmHg increase, HR 
0.99; 95  % CI 0.97–1.00), duration from operation to 
puncture (per 1 day increase, HR 1.00; 95 % CI 0.99–1.00) 
and CV diameter (per 1.0 mm increase, HR 0.86; 95 % CI 
0.59–1.22).
The multivariate analysis revealed that those age of 75 
or more years (HR 2.14; 95  % CI 1.21–3.72), with DM 
(HR 1.82; 95 % CI 1.11–3.02), or with less than 2.0 mm of 
RA diameter (HR 2.83; 95 % CI 1.18–6.06) were at major 
risk factor to early AVF failure, whereas RA blood flow 
(HR 1.21; 95  % CI 0.60–2.62) and BA blood flow (HR 
0.23; 95 % CI 0.02–2.29) were not.
Discussion
Many papers have reported the patency rate of VA, and 
in meta-analysis, the 1-year and 2-year primary patency 
rate of AVF created at the forearm, excluding primary 
AVF failure, were 62 and 51  %, respectively (Al-Jaishi 
et al. 2014). In this study, the 1-year and 2-year patency 
rate was 64.0 and 51.2 %, respectively; therefore our tech-
nical levels of VA operation fall in line with the average 
and are not poor.
The patency rate of this study was significantly lower in 
elderly patients and patients with DM. We have reported 
that AVF blood flow gradually increases after opera-
tion (Sato et  al. 2012). In both elderly and DM patients, 
the progression of arteriosclerosis might have an influ-
ence on the postoperative increment of blood flow and it 
might affect the patency rate. Because the main volume of 
newly started HD patients are in their 70  s in Japan, we 
have divided patients into before and after the age of 75 
and analyzed them. In the univariate analysis of this study, 
it was indicated that at the age of 75 or more, diabetic 
nephropathy, RA diameter of less than 2.0 mm, RA blood 


















Fig. 1 Cumulative primary patency for AVF. The average patency 
time was 448.6 ± 271.3 days. The 1-year and 2-year patency rate were 
64.0 and 51.2 %, respectively (n = 139)






































Fig. 2 The upper panel shows the result of a comparison between 
male and female patency rates. No significant difference was shown 
in the patency rate between both genders (male, solid line, n = 91; 
female, dotted line, n = 48) (p = 0.50). The result of comparison 
between DM and non-DM patients in the patency rate is indicated 
in the lower panel. The patency rate in patients with DM (solid line, 
n = 58) was significantly lower than patients without DM (dotted line, 
n = 81) (p = 0.01)
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flow of less than 20 ml/min, and BA blood flow were risk 
factors for early AVF failure. In particular, depending on 
the US findings, the RA diameter, RA blood flow, and BA 
blood flow might influence the patency rate. However, the 
multivariate analysis has indicated that just an RA diam-
eter of less than 2.0 mm was a risk factor for early AVF 
failure, dependent on US findings. This study has indi-
cated that the blood flow of RA or BA might not affect the 
patency rate. Although it was reported that an RA blood 
flow of 20–40  ml/min might be associated with better 
outcomes of AVF (Sato et  al. 2012; Yerdel et  al. 1997), a 
benchmark of blood flow of BA is not defined. In the uni-
variate analysis, RA and BA blood flow were significantly 
correlated to the patency rate. The RA diameter was a 
stronger contribution factor to the patency rate in mul-
tivariate analysis. A CV diameter of 1.6–2.5  mm with a 
tourniquet was recommended as an anastomosis region 
in some reports (Silva et  al. 1998; Mendes et  al. 2002; 
Malovrh 2002; Wong et al. 1996). However, in this study, 
no relationship between CV diameter and the patency 
rate of AVF was observed. Since the average diameter of 
CV in this study was more than 2.5 mm, the largeness of 
the CV diameter might affect this result. Moreover, one 
report suggested that venous distensibility is a predictor of 
AVF success, whereas luminal diameters are not (van der 
Linden et al. 2006). Other venous factors except for diam-
eter might affect the patency rate. The present study sug-
gests that measurements of RA that are 2.0 mm or more 
in diameter at an anastomosis region measured by US are 
more effective for the improvement in the patency rate 
of VA, in common with many papers that have reported 
that more than a 2.0  mm RA diameter was a successful 
factor for function or prognosis of VA (Allon et al. 2001; 
Mendes et  al. 2002). It has been reported that patency 
rate of VA was significantly lower in female (Kazemza-
deh et  al. 2012). Interestingly, no significant difference 
regarding gender was observed in this study, while the RA 
diameter in females was significantly smaller than that in 
male patients (p = 0.0081). By contrast, age (p = 0.47) and 
CV diameter (p = 0.86) were not different between gen-
ders. Because of the smaller population of DM in female 
patients (p  =  0.07), gender might have no discernible 
impact on the patency rate, despite a smaller RA diameter.
US is a mobile, simple and noninvasive technique that 
provides both anatomic and physiologic data. Many 
European and American papers have suggested that pre-
operative arterial and venous mapping by the B-mode 
method using US is useful for reducing the failure rate of 
forearm fistulas. Moreover, the B-mode and color Dop-
pler methods can successfully detect stenosis, thrombi, 
and aneurysms. The pulse Doppler method is also use-
ful for the observation of blood stream patterns and the 
measurement of blood flow and blood volume in order 
to analyze VA (Allon et  al. 2001; Noto and Noto 2008). 
Similar to these reports, our results suggested that a pre-
operative US examination may allow for a better prog-
nosis of VA in Japanese HD patients. Although the 2011 
update Japanese Society for Dialysis Therapy Guidelines 
of Vascular Access Construction and Repair for Chronic 
Hemodialysis recommends a US examination before VA 
operation (Kukita et  al. 2011), the relationship between 
patency rate of VA and US in Japanese HD patients has 
not been reported. In contrast, many papers from Europe 
or USA had reported this relationship. Therefore, the 
current findings provide important clues for establishing 
the clinical utility of US for VA in Japanese patients. Fur-
ther studies to analyze factors involving the patency rate, 
such as vessel quality including arteriosclerosis or arterial 
calcification, surgical expertise, or dialysis prescription, 
are required. Moreover, further long-term observation is 
also required.
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Fig. 3 The upper panel shows the relationship between age and 
patency rate. The patency rate was also significantly lower in 75 years 
or older patients (dotted line, n = 41) than less than 75 years old 
patients (solid line, n = 98) (p = 0.04). Relationship between diameter 
of RA and patency rate is indicated in the lower panel. US findings of 
2.0 mm or less in RA diameter (solid line, n = 11) are also resulted in a 
significantly lower patency rate than that of more than 2.0 mm (dot-
ted line, n = 128) (p = 0.03)
Page 5 of 7Nakata et al. SpringerPlus  (2016) 5:462 
Nephrologists should make critical decisions regarding 
the choice of renal replacement therapy or take the initia-
tive in performing VA-related procedures themselves. It 
has been reported that minimized delays, decreased hos-
pitalizations, and decreased use of temporary catheters, 
and thereby improved medical care, decreased costs, 
and increased patient convenience, has been made by 
nephrologists in the performance of HD access-related 
procedures (Asif et  al. 2007). The American Society of 
Diagnostic and Interventional Nephrology (ASDIN) 
has established guidelines for training, certification, and 
accreditation of HD vascular access and endovascular 
procedures (American Society of Diagnostic and Inter-
ventional Nephrology 2003). Recommendations for the 
training of European pediatric nephrologists by the Euro-
pean Society for Pediatric Nephrology define pediatric 
nephrologists as those who can acquire the application 
of HD, peritoneal dialysis (PD), and related techniques 
(European Society for Paediatric Nephrology 2001). The 
trainees should acquire skills for the application of HD 
and related techniques, together with vascular access for 
acute and chronic problems (Phadke and Bagga 2005). 
Nephrology practices are now moving toward total dial-
ysis care. In our opinion, which is similar to this trend, 
nephrologists who follow patients with ESKD must 
act as interventional nephrologists. Therefore, skills in 
VA-related procedures, the same as PD-related pro-
cedures (Io et  al. 2014), and in the same way as other 
interventions related to ESKD, must be part of the train-
ing of nephrologists.
Conclusions
In conclusion, it appears that the patency rate was sig-
nificantly lower in elderly patients and patients with DM. 
Moreover, preoperative US findings of the diameter of 
RA may involve the patency rate of VA, making it appears 
that an RA of 2.0 mm or more in diameter at an anasto-
mosis region may be more effective for the improvement 
in the patency rate of VA in Japanese HD patients.
Methods
We designed a cohort study to provide clinical evidence 
of the efficacy of a US examination before VA operation. 
All procedures performed in studies involving human 
participants were in accordance with the ethical stand-
ards of the institutional and/or national research com-
mittee and with the 1964 Helsinki declaration and its 
later amendments or comparable ethical standards and 
the protocol was approved by the Ethics Committee of 
Juntendo University Hospital, Tokyo, Japan. Informed 
consent was obtained from all individual participants 
included in the study.
Patients
The inclusion criteria for our cohort were patients who 
had been given a primary radiocephalic arteriovenous 
Table 3 Contribution factors to the patency rate
CI confidence interval, DM diabetes mellitus, CV cephalic vein, RA radial artery, BA brachial artery
* p value <0.05
Univariate analysis Multivariate analysis
Hazard ratio (95 % CI) p value Hazard ratio (95 % CI) p value
Age (per 1 year) 1.02 (1.00–1.04) 0.0607
 75 or more years old (vs. <75 years old) 1.72 (1.02–2.85) 0.0440* 2.14 (1.21–3.72) 0.0093*
Female (vs. male) 1.19 (0.71–1.97) 0.502
DM (vs. without DM) 1.86 (1.13–3.07) 0.0145* 1.82 (1.11–3.02) 0.0371*
Body height (per 1 cm increase) 0.98 (0.96–1.01) 0.232
Body weight (per 1 kg increase) 1.00 (0.98–1.02) 0.930
Body mass index (per 1 kg/m2 increase) 1.03 (0.97–1.09) 0.345
Systolic blood pressure (per 1 mmHg increase) 1.00 (0.99–1.01) 0.939
Diastolic blood pressure (per 1 mmHg increase) 0.99 (0.97–1.00) 0.132
Duration between operation to puncture (per 1 day) 1.00 (0.99–1.00) 0.487
CV diameter (per 1.0 mm increase) 0.86 (0.59–1.22) 0.402
RA diameter (per 1.0 mm increase) 0.60 (0.34–1.00) 0.0517
 Less than 2.0 mm (vs. 2.0 mm or more) 2.76 (1.26–5.37) 0.0133* 2.83 (1.18–6.06) 0.0215*
RA blood flow (per 1.0 ml/min increase) 0.98 (0.96–0.99) 0.0060* 0.28 (0.01–7.23) 0.485
 Less than 20 ml/min (vs. 20 ml/min or more) 2.04 (1.24–3.40) 0.0048* 1.21 (0.60–2.62) 0.626
BA diameter (per 1.0 mm increase) 0.78 (0.55–1.10) 0.162
BA blood flow (per 1.0 ml/min increase) 0.99 (0.99–1.00) 0.0041* 0.23 (0.02–2.29) 0.221
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fistula (RCAVF) in the forearm from February 2009 to 
December 2010 at the Juntendo University Hospital, 
Tokyo, Japan and had been followed up for 24  months 
(n = 146). Moreover, all of RCAVF were created by side-
to-side anastomosis with the closure of the distal end of 
the vein (considered functionally equivalent to the side 
(artery) to end (vein) anastomosis). An exclusion criterion 
was patients with primary AVF failure, including immedi-
ate failure or early thrombosis within 7 days (n = 7) (Allon 
and Robbin 2002; Miller et al. 2003; Mihmanli et al. 2001).
In total, 139 Japanese patients with ESKD were enrolled 
in this study. Patient characteristics are shown in Table 1.
Preoperative assessment
All patients enrolled in this study were evaluated with a 
physical and US by nephrologists who performed the AVF 
operation. In the physical examination, the pulses at the 
elbows and wrists, and the superficial veins in the forearm 
and upper arm with tourniquet were assessed. Vessels 
were considered suitable if the artery had a good pulsation 
and the vein was patent and of good caliber. US was per-
formed based on a standardized protocol using a LOGIQ 
e or LOGIQ P5 (GE Healthcare Japan, Tokyo, Japan) and 
a 5–13  MHz linear transducer (12L-RS, GE Healthcare, 
Tokyo, Japan) with patients in a recumbent position.
After the application of a tourniquet, the superficial 
veins were followed in cross section with B-mode from 
the mid-upper arm to wrist with intermittent vein com-
pression. The CV was scanned from mid-upper arm to 
wrist. The basilic vein was scanned from the elbow level 
to its drainage into the deep brachial veins. Internal 
diameters and vein depth were measured at an anasto-
mosis presumptive region.
The arterial scan followed the vasculature from the BA 
at the elbow to the RA at the wrist in B-mode. Internal 
diameters and depth of the RA were measured at an anas-
tomosis presumptive region and of the BA at the elbow. 
Longitudinal color flow images were obtained from the 
BA at the elbow to the RA at the wrist. Waveforms were 
recorded from a small sampling volume placed in the 
central flow stream at the attempted angles of 60° relative 
to vessel walls of the artery. Velocity sampling was done 
at RA in an anastomosis presumptive region and BA in 
the elbow by pulse Doppler mode.
Surgical technique
The operation was performed under local anesthesia 
with 1  % lidocaine containing 0.001  % epinephrine. A 
light angle incision was made. Both the CV and the RA 
were isolated as distally as possible on the forearm. The 
CV was dilated by injecting heparinized saline. The end 
of the CV was ligated and the sidewall of CV was anasto-
mosed to the sidewall of the RA using 6-0 polypropylene 
in a smooth loop configuration with a diameter of 6 mm. 
The suturing was initiated with posterior sutures, fol-
lowed by anterior sutures. The operators did not use the 
microscope.
Follow up
We contacted by mail the satellite dialysis clinic where 
patients who had undergone an operation went to receive 
HD therapy from December 2012 to January 2013. We 
obtained information about AVF failure, including the date 
of first access thrombosis or any intervention to maintain 
or restore blood flow, mortality or kidney transplant.
We defined the interval from the time of AVF crea-
tion until first access thrombosis or any intervention to 
maintain or restore blood flow as patency time (primary 
patency) (Lee et al. 2011; Sidawy et al. 2002).
Statistical analysis
The patency rate was estimated using the Kaplan–Meier 
technique. The difference in the patency rate between the 
two groups was examined using a log-rank test. A uni-
variate analysis of categorical variables was made with a 
Chi squared test and a multivariate analysis of AVF sur-
vival was examined by the Cox proportional-hazards 
model. Data were expressed as mean ±  standard devia-
tion (M ±  SD). p  <  0.05 was considered significant. All 
statistical analyses were performed using the Windows 
version of JMP 7.0.2 software (SAS Institute Inc., Cary, 
NC, USA).
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